Kestra Private Wealth Services LLC Boosts Stock Holdings in Stryker Co. (NYSE:SYK)

Kestra Private Wealth Services LLC lifted its holdings in shares of Stryker Co. (NYSE:SYKFree Report) by 4.0% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 15,493 shares of the medical technology company’s stock after purchasing an additional 602 shares during the period. Kestra Private Wealth Services LLC’s holdings in Stryker were worth $4,234,000 as of its most recent filing with the SEC.

Several other hedge funds have also added to or reduced their stakes in the business. Quarry LP purchased a new position in shares of Stryker in the first quarter worth about $27,000. Stone House Investment Management LLC bought a new position in Stryker during the 2nd quarter worth approximately $31,000. Freedom Wealth Alliance LLC purchased a new position in Stryker in the 4th quarter worth approximately $26,000. Rise Advisors LLC boosted its stake in shares of Stryker by 692.9% during the third quarter. Rise Advisors LLC now owns 111 shares of the medical technology company’s stock valued at $30,000 after purchasing an additional 97 shares during the period. Finally, West Tower Group LLC bought a new position in shares of Stryker in the second quarter worth approximately $35,000. 76.24% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on SYK shares. Truist Financial increased their price target on shares of Stryker from $330.00 to $345.00 and gave the company a “hold” rating in a research report on Wednesday. Canaccord Genuity Group raised Stryker from a “hold” rating to a “buy” rating and set a $360.00 target price on the stock in a research note on Wednesday. Citigroup upped their price target on Stryker from $340.00 to $362.00 and gave the company a “buy” rating in a research report on Wednesday. Roth Mkm lifted their price objective on Stryker from $345.00 to $348.00 and gave the stock a “buy” rating in a research report on Wednesday. Finally, Wells Fargo & Company upped their target price on Stryker from $336.00 to $364.00 and gave the company an “overweight” rating in a report on Wednesday. Three research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $331.52.

View Our Latest Stock Analysis on Stryker

Stryker Trading Up 0.4 %

NYSE:SYK opened at $342.05 on Friday. The firm has a market capitalization of $129.94 billion, a P/E ratio of 41.46, a PEG ratio of 2.78 and a beta of 0.90. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.58 and a quick ratio of 0.83. Stryker Co. has a one year low of $249.98 and a one year high of $342.88. The company’s 50-day simple moving average is $302.95 and its 200 day simple moving average is $287.78.

Stryker (NYSE:SYKGet Free Report) last released its earnings results on Tuesday, January 30th. The medical technology company reported $3.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.27 by $0.19. The firm had revenue of $5.82 billion during the quarter, compared to analyst estimates of $5.60 billion. Stryker had a net margin of 15.44% and a return on equity of 22.99%. The business’s revenue was up 11.8% on a year-over-year basis. During the same period last year, the business earned $3.00 earnings per share. As a group, analysts forecast that Stryker Co. will post 11.85 EPS for the current fiscal year.

Stryker Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, January 31st. Investors of record on Friday, December 29th were paid a $0.80 dividend. This is a boost from Stryker’s previous quarterly dividend of $0.75. The ex-dividend date was Thursday, December 28th. This represents a $3.20 dividend on an annualized basis and a yield of 0.94%. Stryker’s payout ratio is presently 38.79%.

Insider Activity at Stryker

In related news, Director Srikant M. Datar sold 500 shares of the company’s stock in a transaction that occurred on Thursday, November 16th. The stock was sold at an average price of $291.92, for a total value of $145,960.00. Following the transaction, the director now directly owns 4,316 shares of the company’s stock, valued at approximately $1,259,926.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, Director Srikant M. Datar sold 500 shares of the business’s stock in a transaction on Thursday, November 16th. The stock was sold at an average price of $291.92, for a total value of $145,960.00. Following the completion of the transaction, the director now owns 4,316 shares in the company, valued at $1,259,926.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Srikant M. Datar sold 750 shares of the stock in a transaction on Tuesday, November 14th. The shares were sold at an average price of $287.57, for a total value of $215,677.50. Following the sale, the director now directly owns 5,316 shares in the company, valued at $1,528,722.12. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 58,306 shares of company stock valued at $16,791,134. 5.90% of the stock is owned by insiders.

Stryker Profile

(Free Report)

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies.

Recommended Stories

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.